Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MARA Holdings (MARA) Research & Development: 2023-2025

Historic Research & Development for Holdings (MARA) over the last 3 years, with Sep 2025 value amounting to $8.7 million.

  • Holdings' Research & Development rose 209.85% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.7 million, marking a year-over-year increase of 195.73%. This contributed to the annual value of $13.2 million for FY2024, which is 370.45% up from last year.
  • Holdings' Research & Development amounted to $8.7 million in Q3 2025, which was up 1.99% from $8.5 million recorded in Q2 2025.
  • In the past 5 years, Holdings' Research & Development ranged from a high of $9.3 million in Q1 2025 and a low of $209,000 during Q1 2023.
  • For the 3-year period, Holdings' Research & Development averaged around $3.9 million, with its median value being $2.8 million (2024).
  • Data for Holdings' Research & Development shows a peak YoY skyrocketed of 1,096.17% (in 2024) over the last 5 years.
  • Over the past 3 years, Holdings' Research & Development (Quarterly) stood at $1.2 million in 2023, then soared by 238.70% to $4.1 million in 2024, then surged by 209.85% to $8.7 million in 2025.
  • Its Research & Development stands at $8.7 million for Q3 2025, versus $8.5 million for Q2 2025 and $9.3 million for Q1 2025.